Twenty‐Year Follow‐Up After Pediatric PBSCT and Living‐Donor Lung Transplantation From the Original Donor: Late Benefit of Belumosudil for Chronic GVHD | Synapse
March 15, 2026
Twenty‐Year Follow‐Up After Pediatric PBSCT and Living‐Donor Lung Transplantation From the Original Donor: Late Benefit of Belumosudil for Chronic GVHD